Vanguard Health Care ETF (VHT)

Add to Watchlists
Create an Alert
119.04 +0.02  +0.02% NYSE Arca Sep 19, 8:00PM BATS Real time Currency in USD
View Full Chart
VHT Price Chart

VHT Description

Vanguard Health Care ETF is a long only equity fund managed by Vanguard that tracks the MSCI US IMI/Health Care 25-50 GR USD index and has 3.368B USD assets under management. It has an expected distribution yield of 0.95%, a Prospective PE Ratio of 20.63, and a Prospective Price to Book Value of 3.522. The fund has a net expense ratio of 0.14%, turns over its positions 5.00% per year, and is traded on the New York Stock Exchange Arca.

Benchmark Index: MSCI US IMI/Health Care 25-50 GR USD

VHT Key Info

Expense Ratio (12-23-13) 0.14%
Assets Under Management (9-15-14) 3.368B
30-Day Average Volume (9-19-14) 188654.6
Net Asset Value (9-18-14) 118.98
Discount or Premium to NAV (9-15-14) 0.00%
Turnover Ratio (8-31-13) 5.00%

VHT Asset Allocation

Type % Net % Long % Short
Cash 0.00% 0.00% 0.00%
Stock 100.00% 100.00% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Aug. 31, 2014

VHT Region Exposure

Americas 96.95%
North America 96.94%
Latin America 0.02%
Greater Europe 3.00%
United Kingdom 0.00%
Europe Developed 3.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.05%
Japan 0.00%
Australasia 0.05%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.00%
As of Aug. 31, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

VHT Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.03%
Energy 0.00%
Financial Services 0.07%
Healthcare 98.44%
Industrials 0.30%
Real Estate 0.00%
Technology 1.16%
Utilities 0.00%
As of Aug. 31, 2014

VHT Stock Market Capitalization

Giant 50.45%
Large 30.89%
Medium 12.54%
Small 4.23%
Micro 1.88%
As of Aug. 31, 2014
View More Holdings

VHT Top 10 Holdings

Name % Weight Price Chg %
Johnson & Johnson 10.10% 107.99 +0.60%
Pfizer Inc 6.44% 30.40 -0.59%
Merck & Co Inc 6.05% 60.49 +0.30%
Gilead Sciences Inc 5.69% 105.96 +0.03%
Amgen Inc 3.63% 144.01 +1.40%
AbbVie Inc 3.03% 59.06 -0.66%
UnitedHealth Group Inc 2.92% 87.80 +0.19%
Bristol-Myers Squibb Company 2.89% 51.51 +0.76%
Biogen Idec Inc 2.80% 329.24 -0.23%
Celgene Corp 2.63% 93.85 +0.62%
As of Aug. 31, 2014
Get Quote for
Advertisement

VHT Risk Info

Beta 0.7629
Max Drawdown (1-26-04 to 9-19-14) 40.83%
30 Day Average Volatility 8.82%

VHT Fundamentals

Dividend Yield TTM (9-19-14) 0.95%
Dividend Yield (Prospective) 1.34%
PE Ratio (Prospective) 20.63
PS Ratio (Prospective) 1.858
Price to Book Value (Prospective) 3.522
ROE 18.30%
ROA 7.42%
Number of Holdings 305.00
As of Aug. 31, 2014

VHT Growth Estimates

Forecasted 5 Yr Earnings Growth 10.17%
Forecasted Book Value Growth 8.75%
Forecasted Cash Flow Growth 1.06%
Forecasted Earnings Growth -13.07%
Forecasted Revenue Growth 7.50%
As of Aug. 31, 2014

VHT Performance

  Returns Total Returns
1M 3.35% 3.35%
3M 7.77% 7.77%
6M 9.02% 9.02%
1Y 25.50% 26.94%
3Y 102.9% 112.3%
5Y 131.1% 152.6%
As of Sept. 18, 2014

VHT Flows

1M 69.49M
3M 59.53M
6M 31.05M
YTD 496.85M
1Y 733.20M
3Y 1.511B
5Y 1.555B
As of Aug. 31, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.